GABAA receptor abnormalities in Prader–Willi syndrome assessed with positron emission tomography and [11C]flumazenil
- 31 May 2004
- journal article
- clinical trial
- Published by Elsevier in NeuroImage
- Vol. 22 (1) , 22-28
- https://doi.org/10.1016/j.neuroimage.2003.10.050
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Drug interactions at GABAA receptorsProgress in Neurobiology, 2002
- GABAA receptor subtypes: dissecting their pharmacological functionsTrends in Pharmacological Sciences, 2001
- Cerebral benzodiazepine receptors in hippocampal sclerosisBrain, 1996
- Stereotaxic Summation Analysis of Human Cerebral Benzodiazepine Binding MapsJournal of Cerebral Blood Flow & Metabolism, 1996
- Which GABAA-receptor subtypes really occur in the brain?Trends in Neurosciences, 1996
- Measurement of Benzodiazepine Receptor Number and Affinity in Humans Using Tracer Kinetic Modeling, Positron Emission Tomography, and [11C]FlumazenilJournal of Cerebral Blood Flow & Metabolism, 1993
- A neuropathological study of a case of the prader-willi syndrome with an interstitial deletion of the proximal long arm of chromosome 15Brain & Development, 1992
- Parametric in vivo imaging of benzodiazepine receptor distribution in human brainAnnals of Neurology, 1991
- The Relationship between Global and Local Changes in PET ScansJournal of Cerebral Blood Flow & Metabolism, 1990
- 11C-labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptorsInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1988